Endothelium-derived C-type natriuretic peptide offsets the pathogenesis of pulmonary hypertension
Joshua P. Dignam(University of Strathclyde), Adrian J. Hobbs(Queen Mary University of London), Ralph T. Schermuly(Justus-Liebig-Universität Gießen), Roula Said Nahal(Queen Mary University of London), Cristina Pérez‐Ternero(Queen Mary University of London), Lucie H. Clapp(The London College), Amie J. Moyes(Queen Mary University of London), Jigisha Patel(University College London), Aisah A. Aubdool(Queen Mary University of London), Vanessa Lowe(Queen Mary University of London), Mario Böhm(Universities of Giessen and Marburg Lung Center)
Cited by 1
Related Papers
Acute Blood Pressure Lowering, Vasoprotective, and Antiplatelet Properties of Dietary Nitrate via Bioconversion to Nitrite
|Hypertension|2008|1.1k
Reversal of experimental pulmonary hypertension by PDGF inhibition
|Journal of Clinical Investigation|2005|1.1k
Mechanisms of disease: pulmonary arterial hypertension
|Nature Reviews Cardiology|2011|784
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390